Report Overview
It is a preparation with better therapeutic effect by delaying drug release rate from the formulation and reducing drug absorption rate into the body.
This report provides a deep insight into the global Sustained Release Injectables market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Sustained Release Injectables Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Sustained Release Injectables market in any manner.
Global Sustained Release Injectables Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AntriaBio
Ascendis Pharma
AstraZeneca
Aurobindo
Avadel
Alkermes
Amylin Pharmaceuticals
Biomarin
Camurus
Critical Pharmaceuticals
Durect
Eli Lilly
Enzon
Ipsen
InnoCore Pharmaceuticals
Janssen
Merck
NanOlogy
Novartis
Oakwood Laboratories/PharmaSophia
OctoPlus
Pacira
PhaseBio Pharmaceuticals
Recipharm AB
Roche
Sanofi
Taiwan Liposome Company (TLC)
Xbrane Biopharma
Livzon Pharm
Luye Pharma Group
Market Segmentation (by Type)
Microparticles
Implants
Gels
Market Segmentation (by Application)
Diabetes
Leukemia
Acromegaly
Ophthalmology
CNS
Rheumatology
Oncology
Reproductive Health
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Sustained Release Injectables Market
? Overview of the regional outlook of the Sustained Release Injectables Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Sustained Release Injectables Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Sustained Release Injectables
1.2 Key Market Segments
1.2.1 Sustained Release Injectables Segment by Type
1.2.2 Sustained Release Injectables Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Sustained Release Injectables Market Overview
2.1 Global Market Overview
2.1.1 Global Sustained Release Injectables Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Sustained Release Injectables Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Sustained Release Injectables Market Competitive Landscape
3.1 Global Sustained Release Injectables Sales by Manufacturers (2019-2024)
3.2 Global Sustained Release Injectables Revenue Market Share by Manufacturers (2019-2024)
3.3 Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Sustained Release Injectables Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Sustained Release Injectables Sales Sites, Area Served, Product Type
3.6 Sustained Release Injectables Market Competitive Situation and Trends
3.6.1 Sustained Release Injectables Market Concentration Rate
3.6.2 Global 5 and 10 Largest Sustained Release Injectables Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Sustained Release Injectables Industry Chain Analysis
4.1 Sustained Release Injectables Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Sustained Release Injectables Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Sustained Release Injectables Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Sustained Release Injectables Sales Market Share by Type (2019-2024)
6.3 Global Sustained Release Injectables Market Size Market Share by Type (2019-2024)
6.4 Global Sustained Release Injectables Price by Type (2019-2024)
7 Sustained Release Injectables Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Sustained Release Injectables Market Sales by Application (2019-2024)
7.3 Global Sustained Release Injectables Market Size (M USD) by Application (2019-2024)
7.4 Global Sustained Release Injectables Sales Growth Rate by Application (2019-2024)
8 Sustained Release Injectables Market Segmentation by Region
8.1 Global Sustained Release Injectables Sales by Region
8.1.1 Global Sustained Release Injectables Sales by Region
8.1.2 Global Sustained Release Injectables Sales Market Share by Region
8.2 North America
8.2.1 North America Sustained Release Injectables Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Sustained Release Injectables Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Sustained Release Injectables Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Sustained Release Injectables Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Sustained Release Injectables Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AntriaBio
9.1.1 AntriaBio Sustained Release Injectables Basic Information
9.1.2 AntriaBio Sustained Release Injectables Product Overview
9.1.3 AntriaBio Sustained Release Injectables Product Market Performance
9.1.4 AntriaBio Business Overview
9.1.5 AntriaBio Sustained Release Injectables SWOT Analysis
9.1.6 AntriaBio Recent Developments
9.2 Ascendis Pharma
9.2.1 Ascendis Pharma Sustained Release Injectables Basic Information
9.2.2 Ascendis Pharma Sustained Release Injectables Product Overview
9.2.3 Ascendis Pharma Sustained Release Injectables Product Market Performance
9.2.4 Ascendis Pharma Business Overview
9.2.5 Ascendis Pharma Sustained Release Injectables SWOT Analysis
9.2.6 Ascendis Pharma Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Sustained Release Injectables Basic Information
9.3.2 AstraZeneca Sustained Release Injectables Product Overview
9.3.3 AstraZeneca Sustained Release Injectables Product Market Performance
9.3.4 AstraZeneca Sustained Release Injectables SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Aurobindo
9.4.1 Aurobindo Sustained Release Injectables Basic Information
9.4.2 Aurobindo Sustained Release Injectables Product Overview
9.4.3 Aurobindo Sustained Release Injectables Product Market Performance
9.4.4 Aurobindo Business Overview
9.4.5 Aurobindo Recent Developments
9.5 Avadel
9.5.1 Avadel Sustained Release Injectables Basic Information
9.5.2 Avadel Sustained Release Injectables Product Overview
9.5.3 Avadel Sustained Release Injectables Product Market Performance
9.5.4 Avadel Business Overview
9.5.5 Avadel Recent Developments
9.6 Alkermes
9.6.1 Alkermes Sustained Release Injectables Basic Information
9.6.2 Alkermes Sustained Release Injectables Product Overview
9.6.3 Alkermes Sustained Release Injectables Product Market Performance
9.6.4 Alkermes Business Overview
9.6.5 Alkermes Recent Developments
9.7 Amylin Pharmaceuticals
9.7.1 Amylin Pharmaceuticals Sustained Release Injectables Basic Information
9.7.2 Amylin Pharmaceuticals Sustained Release Injectables Product Overview
9.7.3 Amylin Pharmaceuticals Sustained Release Injectables Product Market Performance
9.7.4 Amylin Pharmaceuticals Business Overview
9.7.5 Amylin Pharmaceuticals Recent Developments
9.8 Biomarin
9.8.1 Biomarin Sustained Release Injectables Basic Information
9.8.2 Biomarin Sustained Release Injectables Product Overview
9.8.3 Biomarin Sustained Release Injectables Product Market Performance
9.8.4 Biomarin Business Overview
9.8.5 Biomarin Recent Developments
9.9 Camurus
9.9.1 Camurus Sustained Release Injectables Basic Information
9.9.2 Camurus Sustained Release Injectables Product Overview
9.9.3 Camurus Sustained Release Injectables Product Market Performance
9.9.4 Camurus Business Overview
9.9.5 Camurus Recent Developments
9.10 Critical Pharmaceuticals
9.10.1 Critical Pharmaceuticals Sustained Release Injectables Basic Information
9.10.2 Critical Pharmaceuticals Sustained Release Injectables Product Overview
9.10.3 Critical Pharmaceuticals Sustained Release Injectables Product Market Performance
9.10.4 Critical Pharmaceuticals Business Overview
9.10.5 Critical Pharmaceuticals Recent Developments
9.11 Durect
9.11.1 Durect Sustained Release Injectables Basic Information
9.11.2 Durect Sustained Release Injectables Product Overview
9.11.3 Durect Sustained Release Injectables Product Market Performance
9.11.4 Durect Business Overview
9.11.5 Durect Recent Developments
9.12 Eli Lilly
9.12.1 Eli Lilly Sustained Release Injectables Basic Information
9.12.2 Eli Lilly Sustained Release Injectables Product Overview
9.12.3 Eli Lilly Sustained Release Injectables Product Market Performance
9.12.4 Eli Lilly Business Overview
9.12.5 Eli Lilly Recent Developments
9.13 Enzon
9.13.1 Enzon Sustained Release Injectables Basic Information
9.13.2 Enzon Sustained Release Injectables Product Overview
9.13.3 Enzon Sustained Release Injectables Product Market Performance
9.13.4 Enzon Business Overview
9.13.5 Enzon Recent Developments
9.14 Ipsen
9.14.1 Ipsen Sustained Release Injectables Basic Information
9.14.2 Ipsen Sustained Release Injectables Product Overview
9.14.3 Ipsen Sustained Release Injectables Product Market Performance
9.14.4 Ipsen Business Overview
9.14.5 Ipsen Recent Developments
9.15 InnoCore Pharmaceuticals
9.15.1 InnoCore Pharmaceuticals Sustained Release Injectables Basic Information
9.15.2 InnoCore Pharmaceuticals Sustained Release Injectables Product Overview
9.15.3 InnoCore Pharmaceuticals Sustained Release Injectables Product Market Performance
9.15.4 InnoCore Pharmaceuticals Business Overview
9.15.5 InnoCore Pharmaceuticals Recent Developments
9.16 Janssen
9.16.1 Janssen Sustained Release Injectables Basic Information
9.16.2 Janssen Sustained Release Injectables Product Overview
9.16.3 Janssen Sustained Release Injectables Product Market Performance
9.16.4 Janssen Business Overview
9.16.5 Janssen Recent Developments
9.17 Merck
9.17.1 Merck Sustained Release Injectables Basic Information
9.17.2 Merck Sustained Release Injectables Product Overview
9.17.3 Merck Sustained Release Injectables Product Market Performance
9.17.4 Merck Business Overview
9.17.5 Merck Recent Developments
9.18 NanOlogy
9.18.1 NanOlogy Sustained Release Injectables Basic Information
9.18.2 NanOlogy Sustained Release Injectables Product Overview
9.18.3 NanOlogy Sustained Release Injectables Product Market Performance
9.18.4 NanOlogy Business Overview
9.18.5 NanOlogy Recent Developments
9.19 Novartis
9.19.1 Novartis Sustained Release Injectables Basic Information
9.19.2 Novartis Sustained Release Injectables Product Overview
9.19.3 Novartis Sustained Release Injectables Product Market Performance
9.19.4 Novartis Business Overview
9.19.5 Novartis Recent Developments
9.20 Oakwood Laboratories/PharmaSophia
9.20.1 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Basic Information
9.20.2 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Product Overview
9.20.3 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Product Market Performance
9.20.4 Oakwood Laboratories/PharmaSophia Business Overview
9.20.5 Oakwood Laboratories/PharmaSophia Recent Developments
9.21 OctoPlus
9.21.1 OctoPlus Sustained Release Injectables Basic Information
9.21.2 OctoPlus Sustained Release Injectables Product Overview
9.21.3 OctoPlus Sustained Release Injectables Product Market Performance
9.21.4 OctoPlus Business Overview
9.21.5 OctoPlus Recent Developments
9.22 Pacira
9.22.1 Pacira Sustained Release Injectables Basic Information
9.22.2 Pacira Sustained Release Injectables Product Overview
9.22.3 Pacira Sustained Release Injectables Product Market Performance
9.22.4 Pacira Business Overview
9.22.5 Pacira Recent Developments
9.23 PhaseBio Pharmaceuticals
9.23.1 PhaseBio Pharmaceuticals Sustained Release Injectables Basic Information
9.23.2 PhaseBio Pharmaceuticals Sustained Release Injectables Product Overview
9.23.3 PhaseBio Pharmaceuticals Sustained Release Injectables Product Market Performance
9.23.4 PhaseBio Pharmaceuticals Business Overview
9.23.5 PhaseBio Pharmaceuticals Recent Developments
9.24 Recipharm AB
9.24.1 Recipharm AB Sustained Release Injectables Basic Information
9.24.2 Recipharm AB Sustained Release Injectables Product Overview
9.24.3 Recipharm AB Sustained Release Injectables Product Market Performance
9.24.4 Recipharm AB Business Overview
9.24.5 Recipharm AB Recent Developments
9.25 Roche
9.25.1 Roche Sustained Release Injectables Basic Information
9.25.2 Roche Sustained Release Injectables Product Overview
9.25.3 Roche Sustained Release Injectables Product Market Performance
9.25.4 Roche Business Overview
9.25.5 Roche Recent Developments
9.26 Sanofi
9.26.1 Sanofi Sustained Release Injectables Basic Information
9.26.2 Sanofi Sustained Release Injectables Product Overview
9.26.3 Sanofi Sustained Release Injectables Product Market Performance
9.26.4 Sanofi Business Overview
9.26.5 Sanofi Recent Developments
9.27 Taiwan Liposome Company (TLC)
9.27.1 Taiwan Liposome Company (TLC) Sustained Release Injectables Basic Information
9.27.2 Taiwan Liposome Company (TLC) Sustained Release Injectables Product Overview
9.27.3 Taiwan Liposome Company (TLC) Sustained Release Injectables Product Market Performance
9.27.4 Taiwan Liposome Company (TLC) Business Overview
9.27.5 Taiwan Liposome Company (TLC) Recent Developments
9.28 Xbrane Biopharma
9.28.1 Xbrane Biopharma Sustained Release Injectables Basic Information
9.28.2 Xbrane Biopharma Sustained Release Injectables Product Overview
9.28.3 Xbrane Biopharma Sustained Release Injectables Product Market Performance
9.28.4 Xbrane Biopharma Business Overview
9.28.5 Xbrane Biopharma Recent Developments
9.29 Livzon Pharm
9.29.1 Livzon Pharm Sustained Release Injectables Basic Information
9.29.2 Livzon Pharm Sustained Release Injectables Product Overview
9.29.3 Livzon Pharm Sustained Release Injectables Product Market Performance
9.29.4 Livzon Pharm Business Overview
9.29.5 Livzon Pharm Recent Developments
9.30 Luye Pharma Group
9.30.1 Luye Pharma Group Sustained Release Injectables Basic Information
9.30.2 Luye Pharma Group Sustained Release Injectables Product Overview
9.30.3 Luye Pharma Group Sustained Release Injectables Product Market Performance
9.30.4 Luye Pharma Group Business Overview
9.30.5 Luye Pharma Group Recent Developments
10 Sustained Release Injectables Market Forecast by Region
10.1 Global Sustained Release Injectables Market Size Forecast
10.2 Global Sustained Release Injectables Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Sustained Release Injectables Market Size Forecast by Country
10.2.3 Asia Pacific Sustained Release Injectables Market Size Forecast by Region
10.2.4 South America Sustained Release Injectables Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Sustained Release Injectables by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Sustained Release Injectables Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Sustained Release Injectables by Type (2025-2030)
11.1.2 Global Sustained Release Injectables Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Sustained Release Injectables by Type (2025-2030)
11.2 Global Sustained Release Injectables Market Forecast by Application (2025-2030)
11.2.1 Global Sustained Release Injectables Sales (Kilotons) Forecast by Application
11.2.2 Global Sustained Release Injectables Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Sustained Release Injectables Market Size Comparison by Region (M USD)
Table 5. Global Sustained Release Injectables Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Sustained Release Injectables Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Sustained Release Injectables Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Sustained Release Injectables Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2022)
Table 10. Global Market Sustained Release Injectables Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Sustained Release Injectables Sales Sites and Area Served
Table 12. Manufacturers Sustained Release Injectables Product Type
Table 13. Global Sustained Release Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Sustained Release Injectables
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Sustained Release Injectables Market Challenges
Table 22. Global Sustained Release Injectables Sales by Type (Kilotons)
Table 23. Global Sustained Release Injectables Market Size by Type (M USD)
Table 24. Global Sustained Release Injectables Sales (Kilotons) by Type (2019-2024)
Table 25. Global Sustained Release Injectables Sales Market Share by Type (2019-2024)
Table 26. Global Sustained Release Injectables Market Size (M USD) by Type (2019-2024)
Table 27. Global Sustained Release Injectables Market Size Share by Type (2019-2024)
Table 28. Global Sustained Release Injectables Price (USD/Ton) by Type (2019-2024)
Table 29. Global Sustained Release Injectables Sales (Kilotons) by Application
Table 30. Global Sustained Release Injectables Market Size by Application
Table 31. Global Sustained Release Injectables Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Sustained Release Injectables Sales Market Share by Application (2019-2024)
Table 33. Global Sustained Release Injectables Sales by Application (2019-2024) & (M USD)
Table 34. Global Sustained Release Injectables Market Share by Application (2019-2024)
Table 35. Global Sustained Release Injectables Sales Growth Rate by Application (2019-2024)
Table 36. Global Sustained Release Injectables Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Sustained Release Injectables Sales Market Share by Region (2019-2024)
Table 38. North America Sustained Release Injectables Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Sustained Release Injectables Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Sustained Release Injectables Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Sustained Release Injectables Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Sustained Release Injectables Sales by Region (2019-2024) & (Kilotons)
Table 43. AntriaBio Sustained Release Injectables Basic Information
Table 44. AntriaBio Sustained Release Injectables Product Overview
Table 45. AntriaBio Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AntriaBio Business Overview
Table 47. AntriaBio Sustained Release Injectables SWOT Analysis
Table 48. AntriaBio Recent Developments
Table 49. Ascendis Pharma Sustained Release Injectables Basic Information
Table 50. Ascendis Pharma Sustained Release Injectables Product Overview
Table 51. Ascendis Pharma Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ascendis Pharma Business Overview
Table 53. Ascendis Pharma Sustained Release Injectables SWOT Analysis
Table 54. Ascendis Pharma Recent Developments
Table 55. AstraZeneca Sustained Release Injectables Basic Information
Table 56. AstraZeneca Sustained Release Injectables Product Overview
Table 57. AstraZeneca Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AstraZeneca Sustained Release Injectables SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Aurobindo Sustained Release Injectables Basic Information
Table 62. Aurobindo Sustained Release Injectables Product Overview
Table 63. Aurobindo Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Aurobindo Business Overview
Table 65. Aurobindo Recent Developments
Table 66. Avadel Sustained Release Injectables Basic Information
Table 67. Avadel Sustained Release Injectables Product Overview
Table 68. Avadel Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Avadel Business Overview
Table 70. Avadel Recent Developments
Table 71. Alkermes Sustained Release Injectables Basic Information
Table 72. Alkermes Sustained Release Injectables Product Overview
Table 73. Alkermes Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Alkermes Business Overview
Table 75. Alkermes Recent Developments
Table 76. Amylin Pharmaceuticals Sustained Release Injectables Basic Information
Table 77. Amylin Pharmaceuticals Sustained Release Injectables Product Overview
Table 78. Amylin Pharmaceuticals Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Amylin Pharmaceuticals Business Overview
Table 80. Amylin Pharmaceuticals Recent Developments
Table 81. Biomarin Sustained Release Injectables Basic Information
Table 82. Biomarin Sustained Release Injectables Product Overview
Table 83. Biomarin Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Biomarin Business Overview
Table 85. Biomarin Recent Developments
Table 86. Camurus Sustained Release Injectables Basic Information
Table 87. Camurus Sustained Release Injectables Product Overview
Table 88. Camurus Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Camurus Business Overview
Table 90. Camurus Recent Developments
Table 91. Critical Pharmaceuticals Sustained Release Injectables Basic Information
Table 92. Critical Pharmaceuticals Sustained Release Injectables Product Overview
Table 93. Critical Pharmaceuticals Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Critical Pharmaceuticals Business Overview
Table 95. Critical Pharmaceuticals Recent Developments
Table 96. Durect Sustained Release Injectables Basic Information
Table 97. Durect Sustained Release Injectables Product Overview
Table 98. Durect Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Durect Business Overview
Table 100. Durect Recent Developments
Table 101. Eli Lilly Sustained Release Injectables Basic Information
Table 102. Eli Lilly Sustained Release Injectables Product Overview
Table 103. Eli Lilly Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Eli Lilly Business Overview
Table 105. Eli Lilly Recent Developments
Table 106. Enzon Sustained Release Injectables Basic Information
Table 107. Enzon Sustained Release Injectables Product Overview
Table 108. Enzon Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Enzon Business Overview
Table 110. Enzon Recent Developments
Table 111. Ipsen Sustained Release Injectables Basic Information
Table 112. Ipsen Sustained Release Injectables Product Overview
Table 113. Ipsen Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ipsen Business Overview
Table 115. Ipsen Recent Developments
Table 116. InnoCore Pharmaceuticals Sustained Release Injectables Basic Information
Table 117. InnoCore Pharmaceuticals Sustained Release Injectables Product Overview
Table 118. InnoCore Pharmaceuticals Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. InnoCore Pharmaceuticals Business Overview
Table 120. InnoCore Pharmaceuticals Recent Developments
Table 121. Janssen Sustained Release Injectables Basic Information
Table 122. Janssen Sustained Release Injectables Product Overview
Table 123. Janssen Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Janssen Business Overview
Table 125. Janssen Recent Developments
Table 126. Merck Sustained Release Injectables Basic Information
Table 127. Merck Sustained Release Injectables Product Overview
Table 128. Merck Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Merck Business Overview
Table 130. Merck Recent Developments
Table 131. NanOlogy Sustained Release Injectables Basic Information
Table 132. NanOlogy Sustained Release Injectables Product Overview
Table 133. NanOlogy Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. NanOlogy Business Overview
Table 135. NanOlogy Recent Developments
Table 136. Novartis Sustained Release Injectables Basic Information
Table 137. Novartis Sustained Release Injectables Product Overview
Table 138. Novartis Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Novartis Business Overview
Table 140. Novartis Recent Developments
Table 141. Oakwood Laboratories/PharmaSophia Sustained Release Injectables Basic Information
Table 142. Oakwood Laboratories/PharmaSophia Sustained Release Injectables Product Overview
Table 143. Oakwood Laboratories/PharmaSophia Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Oakwood Laboratories/PharmaSophia Business Overview
Table 145. Oakwood Laboratories/PharmaSophia Recent Developments
Table 146. OctoPlus Sustained Release Injectables Basic Information
Table 147. OctoPlus Sustained Release Injectables Product Overview
Table 148. OctoPlus Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. OctoPlus Business Overview
Table 150. OctoPlus Recent Developments
Table 151. Pacira Sustained Release Injectables Basic Information
Table 152. Pacira Sustained Release Injectables Product Overview
Table 153. Pacira Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. Pacira Business Overview
Table 155. Pacira Recent Developments
Table 156. PhaseBio Pharmaceuticals Sustained Release Injectables Basic Information
Table 157. PhaseBio Pharmaceuticals Sustained Release Injectables Product Overview
Table 158. PhaseBio Pharmaceuticals Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 159. PhaseBio Pharmaceuticals Business Overview
Table 160. PhaseBio Pharmaceuticals Recent Developments
Table 161. Recipharm AB Sustained Release Injectables Basic Information
Table 162. Recipharm AB Sustained Release Injectables Product Overview
Table 163. Recipharm AB Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 164. Recipharm AB Business Overview
Table 165. Recipharm AB Recent Developments
Table 166. Roche Sustained Release Injectables Basic Information
Table 167. Roche Sustained Release Injectables Product Overview
Table 168. Roche Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 169. Roche Business Overview
Table 170. Roche Recent Developments
Table 171. Sanofi Sustained Release Injectables Basic Information
Table 172. Sanofi Sustained Release Injectables Product Overview
Table 173. Sanofi Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 174. Sanofi Business Overview
Table 175. Sanofi Recent Developments
Table 176. Taiwan Liposome Company (TLC) Sustained Release Injectables Basic Information
Table 177. Taiwan Liposome Company (TLC) Sustained Release Injectables Product Overview
Table 178. Taiwan Liposome Company (TLC) Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 179. Taiwan Liposome Company (TLC) Business Overview
Table 180. Taiwan Liposome Company (TLC) Recent Developments
Table 181. Xbrane Biopharma Sustained Release Injectables Basic Information
Table 182. Xbrane Biopharma Sustained Release Injectables Product Overview
Table 183. Xbrane Biopharma Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 184. Xbrane Biopharma Business Overview
Table 185. Xbrane Biopharma Recent Developments
Table 186. Livzon Pharm Sustained Release Injectables Basic Information
Table 187. Livzon Pharm Sustained Release Injectables Product Overview
Table 188. Livzon Pharm Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 189. Livzon Pharm Business Overview
Table 190. Livzon Pharm Recent Developments
Table 191. Luye Pharma Group Sustained Release Injectables Basic Information
Table 192. Luye Pharma Group Sustained Release Injectables Product Overview
Table 193. Luye Pharma Group Sustained Release Injectables Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 194. Luye Pharma Group Business Overview
Table 195. Luye Pharma Group Recent Developments
Table 196. Global Sustained Release Injectables Sales Forecast by Region (2025-2030) & (Kilotons)
Table 197. Global Sustained Release Injectables Market Size Forecast by Region (2025-2030) & (M USD)
Table 198. North America Sustained Release Injectables Sales Forecast by Country (2025-2030) & (Kilotons)
Table 199. North America Sustained Release Injectables Market Size Forecast by Country (2025-2030) & (M USD)
Table 200. Europe Sustained Release Injectables Sales Forecast by Country (2025-2030) & (Kilotons)
Table 201. Europe Sustained Release Injectables Market Size Forecast by Country (2025-2030) & (M USD)
Table 202. Asia Pacific Sustained Release Injectables Sales Forecast by Region (2025-2030) & (Kilotons)
Table 203. Asia Pacific Sustained Release Injectables Market Size Forecast by Region (2025-2030) & (M USD)
Table 204. South America Sustained Release Injectables Sales Forecast by Country (2025-2030) & (Kilotons)
Table 205. South America Sustained Release Injectables Market Size Forecast by Country (2025-2030) & (M USD)
Table 206. Middle East and Africa Sustained Release Injectables Consumption Forecast by Country (2025-2030) & (Units)
Table 207. Middle East and Africa Sustained Release Injectables Market Size Forecast by Country (2025-2030) & (M USD)
Table 208. Global Sustained Release Injectables Sales Forecast by Type (2025-2030) & (Kilotons)
Table 209. Global Sustained Release Injectables Market Size Forecast by Type (2025-2030) & (M USD)
Table 210. Global Sustained Release Injectables Price Forecast by Type (2025-2030) & (USD/Ton)
Table 211. Global Sustained Release Injectables Sales (Kilotons) Forecast by Application (2025-2030)
Table 212. Global Sustained Release Injectables Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Sustained Release Injectables
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Sustained Release Injectables Market Size (M USD), 2019-2030
Figure 5. Global Sustained Release Injectables Market Size (M USD) (2019-2030)
Figure 6. Global Sustained Release Injectables Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Sustained Release Injectables Market Size by Country (M USD)
Figure 11. Sustained Release Injectables Sales Share by Manufacturers in 2023
Figure 12. Global Sustained Release Injectables Revenue Share by Manufacturers in 2023
Figure 13. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Sustained Release Injectables Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Sustained Release Injectables Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Sustained Release Injectables Market Share by Type
Figure 18. Sales Market Share of Sustained Release Injectables by Type (2019-2024)
Figure 19. Sales Market Share of Sustained Release Injectables by Type in 2023
Figure 20. Market Size Share of Sustained Release Injectables by Type (2019-2024)
Figure 21. Market Size Market Share of Sustained Release Injectables by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Sustained Release Injectables Market Share by Application
Figure 24. Global Sustained Release Injectables Sales Market Share by Application (2019-2024)
Figure 25. Global Sustained Release Injectables Sales Market Share by Application in 2023
Figure 26. Global Sustained Release Injectables Market Share by Application (2019-2024)
Figure 27. Global Sustained Release Injectables Market Share by Application in 2023
Figure 28. Global Sustained Release Injectables Sales Growth Rate by Application (2019-2024)
Figure 29. Global Sustained Release Injectables Sales Market Share by Region (2019-2024)
Figure 30. North America Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Sustained Release Injectables Sales Market Share by Country in 2023
Figure 32. U.S. Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Sustained Release Injectables Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Sustained Release Injectables Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Sustained Release Injectables Sales Market Share by Country in 2023
Figure 37. Germany Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Sustained Release Injectables Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Sustained Release Injectables Sales Market Share by Region in 2023
Figure 44. China Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Sustained Release Injectables Sales and Growth Rate (Kilotons)
Figure 50. South America Sustained Release Injectables Sales Market Share by Country in 2023
Figure 51. Brazil Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Sustained Release Injectables Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Sustained Release Injectables Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Sustained Release Injectables Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Sustained Release Injectables Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Sustained Release Injectables Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Sustained Release Injectables Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Sustained Release Injectables Market Share Forecast by Type (2025-2030)
Figure 65. Global Sustained Release Injectables Sales Forecast by Application (2025-2030)
Figure 66. Global Sustained Release Injectables Market Share Forecast by Application (2025-2030)
